Metamizole-induced agranulocytosis: utilisation trends, pharmacovigilance signals and regulatory risk-minimisation in Switzerland. Swiss Med Wkly [Internet]. 2026 Jun. 26 [cited 2026 Jul. 25];156(6):5062. Available from: https://smw.ch/index.php/smw/article/view/5062